Molecular Field Analysis and 3D-Quantitative Structure-Activity Relationship Study (MFA 3D-QSAR) Unveil Novel Features of Bile Acid Recognition at TGR5

Bile acids regulate nongenomic actions through the activation of TGR5, a membrane receptor that is G protein-coupled to the induction of adenylate cyclase. In this work, a training set of 43 bile acid derivatives is used to develop a molecular interaction field analysis (MFA) and a 3D-quantitative structure-activity relationship study (3D-QSAR) of TGR5 agonists. The predictive ability of the resulting model is evaluated using an external set of compounds with known TGR5 activity, and six bile acid derivatives whose unknown TGR5 activity is herein assessed with in vitro luciferase assay of cAMP formation. The results show a good predictive model and indicate a statistically relevant degree of correlation between the TGR5 activity and the molecular interaction fields produced by discrete positions of the bile acid scaffold. This information is instrumental to extend on a quantitative basis the current structure-activity relationships of bile acids as TGR5 modulators and will be fruitful to design new potent and selective agonists of the receptor.

[1]  J. Gasteiger,et al.  ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES , 1980 .

[2]  Masataka Harada,et al.  A G Protein-coupled Receptor Responsive to Bile Acids* , 2003, The Journal of Biological Chemistry.

[3]  J. Lehmann,et al.  Bile acids: natural ligands for an orphan nuclear receptor. , 1999, Science.

[4]  S. Fiorucci,et al.  Farnesoid X receptor: from structure to potential clinical applications. , 2005, Journal of medicinal chemistry.

[5]  T. Willson,et al.  Bile acid derivatives as ligands of the farnesoid X receptor. Synthesis, evaluation, and structure-activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acid. , 2004, Journal of medicinal chemistry.

[6]  G. Costantino,et al.  Binding mode of 6ECDCA, a potent bile acid agonist of the farnesoid X receptor (FXR). , 2003, Bioorganic & medicinal chemistry letters.

[7]  J. Auwerx,et al.  Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea. , 2007, Biochemical and biophysical research communications.

[8]  G. Tsujimoto,et al.  Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. , 2005, Biochemical and biophysical research communications.

[9]  H. Miyoshi,et al.  Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice. , 2006, The Journal of endocrinology.

[10]  D. Mangelsdorf,et al.  Synthesis, characterization, and receptor interaction profiles of enantiomeric bile acids. , 2007, Journal of medicinal chemistry.

[11]  D. Pfaff,et al.  Membrane-initiated actions of estrogens in neuroendocrinology: emerging principles. , 2007, Endocrine reviews.

[12]  J. Auwerx,et al.  Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies. , 2008, Journal of medicinal chemistry.

[13]  Johan Auwerx,et al.  Nuclear receptors and the control of metabolism. , 2003, Annual review of physiology.

[14]  K. Setchell,et al.  3α-6α-Dihydroxy-7α-fluoro-5β-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17α-ethynyl-estradiol-induced cholestasis in rats , 2006 .

[15]  M. Bowman,et al.  A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR. , 2003, Molecular cell.

[16]  J. Auwerx,et al.  Bile acids and the membrane bile acid receptor TGR5--connecting nutrition and metabolism. , 2008, Thyroid : official journal of the American Thyroid Association.

[17]  Takao Nakamura,et al.  Identification of membrane-type receptor for bile acids (M-BAR). , 2002, Biochemical and biophysical research communications.

[18]  E. Distrutti,et al.  Targeting farnesoid X receptor for liver and metabolic disorders. , 2007, Trends in molecular medicine.

[19]  Min-Bo Chen,et al.  3D-QSAR studies with the aid of molecular docking for a series of non-steroidal FXR agonists. , 2007, Bioorganic & medicinal chemistry letters.

[20]  J. Auwerx,et al.  Endocrine functions of bile acids , 2006, The EMBO journal.

[21]  W. A. Goddard,et al.  a Full Periodic Table Force Field for Molecular Mechanics and Molecular Dynamics Simulations , 2022 .

[22]  G. Costantino,et al.  Molecular dynamics simulation of the ligand binding domain of farnesoid X receptor. Insights into helix-12 stability and coactivator peptide stabilization in response to agonist binding. , 2005, Journal of medicinal chemistry.

[23]  J. Auwerx,et al.  Nongenomic actions of bile acids. Synthesis and preliminary characterization of 23- and 6,23-alkyl-substituted bile acid derivatives as selective modulators for the G-protein coupled receptor TGR5. , 2007, Journal of medicinal chemistry.

[24]  M. Wehling.  Nongenomic actions of steroid hormones , 1994, Trends in Endocrinology & Metabolism.

[25]  Stephen R. Johnson,et al.  The Trouble with QSAR (or How I Learned To Stop Worrying and Embrace Fallacy) , 2008, J. Chem. Inf. Model..

[26]  Rakesh Kumar,et al.  Signaling regulation of genomic and nongenomic functions of estrogen receptors. , 2006, Cancer letters.

[27]  J. Auwerx,et al.  Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation , 2006, Nature.

[28]  A. Moschetta,et al.  Nuclear bile acid receptor FXR as pharmacological target: Are we there yet? , 2006, FEBS letters.

[29]  T. Willson,et al.  6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity. , 2002, Journal of medicinal chemistry.

[30]  Gerald M. Maggiora,et al.  On Outliers and Activity Cliffs-Why QSAR Often Disappoints , 2006, J. Chem. Inf. Model..

[31]  Roberto Pellicciari,et al.  Structural basis for bile acid binding and activation of the nuclear receptor FXR. , 2003, Molecular cell.

[32]  M. Makishima,et al.  Identification of a nuclear receptor for bile acids. , 1999, Science.

[33]  J. Topliss,et al.  CHANCE FACTORS IN STUDIES OF QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS , 1980 .

[34]  Jasmine Chen,et al.  Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. , 1999, Molecular cell.